The evolving landscape of biomarker testing for non-small cell lung cancer in Europe
| dc.contributor.author | Kerr, Keith | |
| dc.contributor.author | Bibeau, Frédéric | |
| dc.contributor.author | Thunnissen, Erik | |
| dc.contributor.author | Botling, Johan | |
| dc.contributor.author | Ryška, Aleš | |
| dc.contributor.author | Wolf, Jürgen | |
| dc.contributor.author | Öhrling, Katarina | |
| dc.contributor.author | Burdon, Peter | |
| dc.contributor.author | Malapelle, Umberto | |
| dc.contributor.author | Büttner, Reinhard | |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.date.accessioned | 2021-11-15T10:16:01Z | |
| dc.date.available | 2021-11-15T10:16:01Z | |
| dc.date.issued | 2021-12-01 | |
| dc.description | Funding Supported by Amgen (Europe) GmbH (Rotkreuz, Switzerland). | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 15 | |
| dc.format.extent | 5249632 | |
| dc.identifier | 208627741 | |
| dc.identifier | b253e398-ed64-4cbd-b6e0-8731650b6c43 | |
| dc.identifier | 85101988217 | |
| dc.identifier.citation | Kerr, K, Bibeau, F, Thunnissen, E, Botling, J, Ryška, A, Wolf, J, Öhrling, K, Burdon, P, Malapelle, U & Büttner, R 2021, 'The evolving landscape of biomarker testing for non-small cell lung cancer in Europe', Lung Cancer, vol. 154, pp. 161-175. https://doi.org/10.1016/j.lungcan.2021.02.026 | en |
| dc.identifier.doi | 10.1016/j.lungcan.2021.02.026 | |
| dc.identifier.issn | 0169-5002 | |
| dc.identifier.uri | https://hdl.handle.net/2164/17493 | |
| dc.identifier.vol | 154 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Lung Cancer | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | precision medicine | en |
| dc.subject | predictive molecular pathology | en |
| dc.subject | targeted therapies | en |
| dc.subject | Next generation sequencing | en |
| dc.subject | oncogenic driver mutations | en |
| dc.subject | NSCLC | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | The evolving landscape of biomarker testing for non-small cell lung cancer in Europe | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Kerr_etal_LC_the_evolving_landscape_VOR.pdf
- Size:
- 5.01 MB
- Format:
- Adobe Portable Document Format
